Urinary incontinence in adults (stress, urgency/OAB, mixed, overflow, functional)
Bedside summary
Involuntary leakage of urine; common, under-reported and often treatable. Classify by type to guide management: stress (leak on cough/exertion — sphincter/pelvic floor weakness), urgency/overactive bladder (sudden compelling urge, detrusor overactivity), mixed, overflow (chronic retention — BPH, neurogenic, drugs), and functional (mobility/cognition prevent reaching toilet). Always first exclude and treat reversible causes (the 'DIAPPERS': Delirium, Infection (symptomatic UTI), Atrophic vaginitis, Pharmaceuticals, Psychological, Excess urine output, Restricted mobility, Stool impaction).
Red flags
- Visible haematuria, or microscopic haematuria in adults >=45 with risk factors — 2-week-wait for bladder cancer
- Painful bladder, recurrent UTIs, suspected fistula or malignant mass
- New neurological signs / suspected cauda equina (saddle anaesthesia, bilateral leg symptoms, acute retention with overflow) — emergency
- Palpable bladder / high post-void residual (obstruction, risk of obstructive AKI)
- Pelvic organ prolapse beyond introitus
Assessment
Differential diagnosis
- Stress urinary incontinence (pelvic floor/sphincter weakness, post-prostatectomy)
- Urgency incontinence / overactive bladder (detrusor overactivity)
- Mixed incontinence
- Overflow incontinence / chronic retention (BPH, neurogenic bladder, anticholinergic/opioid drugs, faecal impaction)
- Functional incontinence (immobility, dementia, environment)
- Fistula (vesicovaginal — obstetric, post-surgical, post-radiation; consider in India post-obstructed labour)
- Reversible: symptomatic UTI, atrophic vaginitis, diuretics/hyperglycaemia/hypercalcaemia, constipation, delirium
Investigations
- Bladder diary (frequency/volume chart) over 3 days
- Urinalysis — treat only if symptomatic UTI; do NOT treat asymptomatic bacteriuria
- Post-void residual (bladder scan) — exclude chronic retention/overflow (e.g. >150-200 mL abnormal) [verify local threshold]
- U&E, glucose, calcium (polyuria causes)
- Examination: abdominal (palpable bladder), pelvic (prolapse, atrophy), cough stress test, DRE (prostate, faecal impaction, tone), neurological if indicated
- Specialist: urodynamics before surgery or when diagnosis unclear
Management
- Identify and reverse DIAPPERS causes first (treat symptomatic UTI, relieve constipation, review drugs, treat atrophy)
- Classify incontinence type clinically
- Lifestyle first-line: weight loss if BMI high, reduce caffeine/alcohol, modify fluid intake (not excessive restriction), smoking cessation, timed/prompted voiding, treat constipation
- Stress UI: supervised pelvic floor muscle training >=3 months (>=8 contractions x3/day); then consider surgery (colposuspension, autologous sling) or duloxetine if surgery declined
- Urgency UI/OAB: bladder retraining >=6 weeks; then antimuscarinic or mirabegron; consider botulinum toxin A, percutaneous tibial nerve stimulation or sacral neuromodulation if refractory
- Overflow/retention: relieve retention (catheter), treat cause (alpha-blocker +/- 5-alpha-reductase inhibitor for BPH, review anticholinergics), teach intermittent self-catheterisation if neurogenic
- Functional: optimise mobility, toileting aids, commode, clothing, containment products as adjunct not substitute
- Refer to continence service / urogynaecology / urology if red flags, refractory, or surgery considered
Drugs & doses
Disposition
Complications & pitfalls
- Obstructive uropathy / AKI from unrecognised chronic retention
- Recurrent UTI, skin breakdown / incontinence-associated dermatitis, pressure ulcers
- Falls (nocturia, rushing to toilet), social isolation, depression, carer strain, institutionalisation
- Anticholinergic cognitive decline from OAB drugs
Exam pearls
- Guideline: NICE NG123 (urinary incontinence and pelvic organ prolapse in women); OAB management per NICE/EAU.
- Always exclude chronic retention with overflow before starting an antimuscarinic — it will worsen retention.
- Prefer mirabegron or once-daily/trospium antimuscarinics in older/cognitively impaired patients; immediate-release oxybutynin is a classic STOPP-criterion drug.
- Containment products manage symptoms but are not a diagnosis or a cure — always assess and treat the cause.
- Do not catheterise or antibiotic-treat an older patient for 'incontinence' alone without urinary symptoms.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.